Medpace Holdings is trading at $565.61, down -6.18% versus the prior close; no confirmed catalyst has been identified for the October 7, 2026 pre-market decline. - No fresh company-specific announcement explaining the move was found. - Broader markets are mixed to slightly lower in the supplied context, which does not establish a clear market-wide explanation. Q3 2026 results are scheduled after market close on October 21.